Palantir: Stock Richly Valued, Is Growth Still Worth It?
Palantir trades at lofty multiples, but its growth engine is real. This piece weighs the high valuation against the b...
Compounding is essential for effective wealth building. Discover why it matters and how to incorporate it into your financial plans.
21,125 articlesPalantir trades at lofty multiples, but its growth engine is real. This piece weighs the high valuation against the b...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Supermicro, a key Nvidia partner, has not named a permanent CFO more than a year after an EY-led review urged leaders...
The iconic Atari brand is tapping public investors to back the first Atari Hotel, a Phoenix project blending gaming, ...
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...
META sits at a pivotal moment. With AI-enabled engagement, ad momentum, and new monetization paths, analysts wonder i...
Prediction markets hint at a tiny chance of Bitcoin reaching $150K by June. This article explains why those odds exis...
Campbell's is flirting with S&P 500 membership risk as its market cap stays among the smallest. Yet the stock's solid...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
Microsoft has faced a sharp pullback as AI spending and cloud dynamics shift. This article weighs the risks and oppor...
Netflix shares jumped after price hikes, signaling pricing power in streaming. This in-depth look explains what happe...
Biotech stocks can swing wildly on quarterly results and guidance. This article unpacks why genedx stock plummeting t...